Engineered Methioninase-expressing Tumor-targeting<i>Salmonella typhimurium</i>A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine

Tumor-targeting <i>Salmonella typhimurium</i> A1-R engineered to express the <i>Pseudomonas putida methioninase</i> gene, inhibited LLC tumor growth in a syngeneic mouse model and reduced the methionine level in the tumor. <i>Salmonella typhimurium</i> A1-R-rMETase combines the tumor targeting and killing capability of <i>Salmonella typhimurium</i> A1-R plus rMETase which targets the methionine addiction of cancer.

Authors

Institutions

Publication Details

Journal
Cancer Genomics & Proteomics
Published
2025-02-24
DOI
https://doi.org/10.21873/cgp.20499
Citations
2
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
2.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engineered Methioninase-expressing Tumor-targetingSalmonella typhimuriumA1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine

Takuya Tsunoda, Yutaro Kubota, Michael Bouvet, Ming Zhao et al.
2 citations
Cancer Genomics & Proteomics
Cancer Research and Treatments
2.47
article

Engineered Methioninase-expressing Tumor-targetingSalmonella typhimuriumA1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine

Takuya Tsunoda, Yutaro Kubota, Michael Bouvet, Ming Zhao, Koichi Kubota, MOTOKAZU SATO, Koya Obara, KOHEI MIZUTA, NORIYUKI MASAKI, Sei Morinaga, YUSUKE AOKI, Robert M. Hoffman, Qinghong Han
article en
2 citations

Abstract

Tumor-targeting <i>Salmonella typhimurium</i> A1-R engineered to express the <i>Pseudomonas putida methioninase</i> gene, inhibited LLC tumor growth in a syngeneic mouse model and reduced the methionine level in the tumor. <i>Salmonella typhimurium</i> A1-R-rMETase combines the tumor targeting and killing capability of <i>Salmonella typhimurium</i> A1-R plus rMETase which targets the methionine addiction of cancer.

Cancer Genomics & ProteomicsVol. 22(2)
SHOWA Medical University (JP), University of California San Diego (US), AntiCancer (United States) (US), Kitasato University (JP)
Openalex Percentile: Top 14%
Cancer Research and Treatments
2.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.